Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chemokine-like receptor 1 (CMKLR1), also known as ChemR23 or chemerin receptor 23, is a G protein-coupled receptor (GPCR). It primarily binds the adipokine chemerin and the specialized pro-resolving lipid mediator resolvin E1. CMKLR1 is expressed by immune cells (macrophages, dendritic cells, NK cells, microglia), cardiomyocytes, adipocytes, and endothelial cells. Activation of CMKLR1 mobilizes intracellular calcium and triggers signaling pathways. It is involved in chemoattraction of immune cells, inflammation modulation, metabolic regulation, and angiogenesis. Targeting CMKLR1 has therapeutic potential in neuroinflammatory diseases and metabolic disorders.
Activation of CMKLR1 mobilizes intracellular calcium and triggers signaling pathways including ERK1/2 and NF-kB. Chemerin/CMKLR1 interaction promotes migration of immune cells and may also help resolve inflammation through enhanced efferocytosis. Resolvin E1 binding to CMKLR1 suppresses leukocyte infiltration during inflammatory responses.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine-like receptor 1 (CMKLR1).